# Inner Logic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inner-logic

- Industry: Software
- Headquarters: Baltimore, US
- Website: www.innerlogic.io
- Total disclosed funding: $12M
- Latest round: Seed (Jul 22, 2026)
- Investors on record: 9

## About

Inner Logic Inc. is a US-based company specializing in advanced development infrastructure for procedural medical devices, enhancing performance through intelligent and autonomous systems.Founded in 2026 and headquartered in Baltimore, US, Inner Logic Inc. focuses on innovative solutions in the medical device sector. The company has successfully completed one funding round, raising USD 11.5 mn in Seed funding on July 22, 2026, co-led by Bison Ventures and General Catalyst Partners, with participation from several other investors.Inner Logic specializes in advanced development infrastructure for procedural medical devices, including orthopedic implants, heart valves, and surgical robots. Their offerings emphasize a software-defined framework that accelerates development cycles, allowing medical device manufacturers to transition from concept to production in days rather than months. Their solutions leverage cloud-based simulations to minimize reliance on cadaveric testing, optimizing resource allocation for clients. The primary markets for these products are North America and Europe, addressing the increasing demand for innovative surgical solutions.Inner Logic generates revenue through partnerships and direct transactions with clients in the medical device sector. Their transaction structure includes annual subscriptions for access to their development platform and project-based fees tied to specific device projects. Clients engage in comprehensive contracts for services, including simulation and regulatory support, ensuring compliance throughout the development process. Their pricing strategies are tailored to accommodate a diverse client base, from startups to established firms in the medical sector.In July 2026, Inner Logic Inc. secured USD 11.5 mn in Seed funding to enhance its simulation platform and support medical device companies focusing on both conventional and autonomous surgical systems. The company aims to expand its product offerings and geographic reach, targeting additional markets in Europe and Asia by 2027. This funding will enable the development of new products designed to further streamline the device creation process and address emerging needs in the surgical sector.

## Funding rounds

- Seed, Jul 22, 2026, $12M — General Catalyst Partners, Alumni Ventures Group, Valia Ventures, Page One Ventures, PTX Capital, J2 Ventures, Bison Ventures, Defined Capital, Flare

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- Valia Ventures (https://capitalatlas.ai/funds/valia-ventures) — Seed
- Page One Ventures (https://capitalatlas.ai/funds/page-one-ventures) — Seed
- PTX Capital (https://capitalatlas.ai/funds/ptx-capital) — Seed
- J2 Ventures (https://capitalatlas.ai/funds/j2-ventures) — Seed
- Bison Ventures (https://capitalatlas.ai/funds/bison-ventures) — Seed
- Defined Capital (https://capitalatlas.ai/funds/defined-capital) — Seed
- Flare — Seed